Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXPG1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,515
Award facts
- Contract value 100% obligated
- $10,515.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,515.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on December 5, 2025, with completion scheduled for December 8, 2025. This delivery order represents a non-competed award under a larger indefinite delivery contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used in diabetes and weight management treatment, reflecting the Defense Health System's pharmaceutical procurement needs.
This award is issued as a child order under AmerisourceBergen Drug Corp's existing $999.999 billion indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with DLA and routinely fulfills orders for specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's performance under this prime vendor agreement enables it to supply critical pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FXPG1?
SPE2DR26FXPG1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FXPG1 worth?
The government has obligated $10,515 on SPE2DR26FXPG1.
Is contract SPE2DR26FXPG1 an order under another contract?
Yes. SPE2DR26FXPG1 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXPG1 competed?
The extent of competition for SPE2DR26FXPG1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award